Skip to main content
TipRanks
Go Ultimate75% OFF

Harry A Glorikian Insider Profile

4 Followers

Harry A Glorikian, Director at StageZero Life Sciences Ltd, holds 107.15K shares in StageZero Life Sciences Ltd (Ticker: TSE:SZLS.H).

Harry A Glorikian's Trading History

SZLS.H
StageZero Life Sciences Ltd
Dec 24, 2020DirectorUninformative Sell8.67KC$4.29K
TSE:SZLS.H
Insider Shares: 107.15K (17.03%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 24, 2020Uninformative SellC$8.67K36,120C$0.24――
Jul 17, 2017Uninformative BuyC$130.70K568,275C$0.23――
Aug 30, 2016Informative Sell$29.00K200,000$0.14+45.20%―
Jul 10, 2014Informative BuyC$206.00K200,000C$1.03-73.60%―

You May Also Like

Harry A Glorikian insider profile FAQ

What is the percentage of profitable transactions made by Harry A Glorikian?
The percentage of profitable transactions made by Harry A Glorikian is 50%.
What is the average return per transaction made by Harry A Glorikian?
The average return per transaction made by Harry A Glorikian is -14.20%.
What stocks does Harry A Glorikian hold?
Harry A Glorikian holds: TSE:SZLS.H stocks.
What was Harry A Glorikian’s latest transaction?
Harry A Glorikian’s latest transaction was an Uninformative Sell of C$8.67K.
What was Harry A Glorikian's most profitable transaction?
Harry A Glorikian’s most profitable transaction was an Informative Sell of TSE:SZLS.H stock on August 30, 2016. The return on the trade was 45.20%.
What is Harry A Glorikian's role in StageZero Life Sciences Ltd?
Harry A Glorikian's role in StageZero Life Sciences Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.